Wednesday, April 24, 2019 9:20:39 AM
what are you think ? I should go in again I m thinking 1.2$ -1.9$ around this stock staying
couple months Lets see but I m going to find better one
couple months Lets see but I m going to find better one
Recent MBRX News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 03:40:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/15/2026 04:15:07 AM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/14/2026 09:26:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/14/2026 08:56:35 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/27/2026 08:01:09 PM
- Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout • GlobeNewswire Inc. • 03/23/2026 12:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 12:45:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 12:35:12 PM
- Moleculin to Present at 38th Annual ROTH Conference • GlobeNewswire Inc. • 03/17/2026 01:05:00 PM
- Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study • GlobeNewswire Inc. • 03/11/2026 01:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 07:58:05 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 07:09:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 01:50:23 PM
- Moleculin shares slide sharply after warrant exercise deal • IH Market News • 02/19/2026 03:46:31 PM
- Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds • GlobeNewswire Inc. • 02/19/2026 01:39:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:31:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:20:16 PM
- Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30) • GlobeNewswire Inc. • 02/18/2026 01:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 01:35:16 PM
- Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin • GlobeNewswire Inc. • 02/17/2026 01:35:00 PM
- Moleculin Launches CEO Corner Platform to Share Strategic Insights • GlobeNewswire Inc. • 02/13/2026 01:32:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2026 04:55:04 PM
- Moleculin to Participate in the Corporate Connect Webinar Series Virtual Conference Hosted by Webull Financial • GlobeNewswire Inc. • 02/05/2026 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/20/2026 01:00:17 PM
